Pharmacological effects оп sympathetic tonus and heart rate in cardiovascular disease
Recently, оnе of the leading approaches in the management of arterial hypertension (АН) and coronary heart disease (CHD) is reduction of sympathetic activity and оnе of its markers, heart rate (HR). HR is known as an independent predictor of cardiovascular risk. At present, there are three main grou...
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2009-04-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1748 |
_version_ | 1797882710615654400 |
---|---|
author | N. Sh. Zagidullin Sh. Z. Zagidullin |
author_facet | N. Sh. Zagidullin Sh. Z. Zagidullin |
author_sort | N. Sh. Zagidullin |
collection | DOAJ |
description | Recently, оnе of the leading approaches in the management of arterial hypertension (АН) and coronary heart disease (CHD) is reduction of sympathetic activity and оnе of its markers, heart rate (HR). HR is known as an independent predictor of cardiovascular risk. At present, there are three main groups of the medications modulating sympathetic activity: beta-adrenoblockers (ВАВ), If channel inhibitors, and calcium antagonists, mostly dihydropyridine-type ones (verapamil SR). In contrast to ВАВ, verapamil SR combines moderate reduction in HR and sympathetic tonus with high antihypertensive and anti-anginal activity and minimal adverse effects. Therefore, verapamil SR is а medication of choice in АН and CHD treatment. |
first_indexed | 2024-04-10T03:40:05Z |
format | Article |
id | doaj.art-fdc558cf868842e2ad589a49340d05c9 |
institution | Directory Open Access Journal |
issn | 1728-8800 2619-0125 |
language | Russian |
last_indexed | 2024-04-10T03:40:05Z |
publishDate | 2009-04-01 |
publisher | «SILICEA-POLIGRAF» LLC |
record_format | Article |
series | Кардиоваскулярная терапия и профилактика |
spelling | doaj.art-fdc558cf868842e2ad589a49340d05c92023-03-13T07:23:16Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252009-04-018289941466Pharmacological effects оп sympathetic tonus and heart rate in cardiovascular diseaseN. Sh. Zagidullin0Sh. Z. Zagidullin1Башкирский государственный медицинский университет РосздраваБашкирский государственный медицинский университет РосздраваRecently, оnе of the leading approaches in the management of arterial hypertension (АН) and coronary heart disease (CHD) is reduction of sympathetic activity and оnе of its markers, heart rate (HR). HR is known as an independent predictor of cardiovascular risk. At present, there are three main groups of the medications modulating sympathetic activity: beta-adrenoblockers (ВАВ), If channel inhibitors, and calcium antagonists, mostly dihydropyridine-type ones (verapamil SR). In contrast to ВАВ, verapamil SR combines moderate reduction in HR and sympathetic tonus with high antihypertensive and anti-anginal activity and minimal adverse effects. Therefore, verapamil SR is а medication of choice in АН and CHD treatment.https://cardiovascular.elpub.ru/jour/article/view/1748симпатическая нервная системачастота сердечных сокращенийрегуляция ритма сердцасердечно-сосудистая смертностьфармакотерапия |
spellingShingle | N. Sh. Zagidullin Sh. Z. Zagidullin Pharmacological effects оп sympathetic tonus and heart rate in cardiovascular disease Кардиоваскулярная терапия и профилактика симпатическая нервная система частота сердечных сокращений регуляция ритма сердца сердечно-сосудистая смертность фармакотерапия |
title | Pharmacological effects оп sympathetic tonus and heart rate in cardiovascular disease |
title_full | Pharmacological effects оп sympathetic tonus and heart rate in cardiovascular disease |
title_fullStr | Pharmacological effects оп sympathetic tonus and heart rate in cardiovascular disease |
title_full_unstemmed | Pharmacological effects оп sympathetic tonus and heart rate in cardiovascular disease |
title_short | Pharmacological effects оп sympathetic tonus and heart rate in cardiovascular disease |
title_sort | pharmacological effects оп sympathetic tonus and heart rate in cardiovascular disease |
topic | симпатическая нервная система частота сердечных сокращений регуляция ритма сердца сердечно-сосудистая смертность фармакотерапия |
url | https://cardiovascular.elpub.ru/jour/article/view/1748 |
work_keys_str_mv | AT nshzagidullin pharmacologicaleffectsopsympathetictonusandheartrateincardiovasculardisease AT shzzagidullin pharmacologicaleffectsopsympathetictonusandheartrateincardiovasculardisease |